ICU Medical, Inc. develops, manufactures, and sells innovative medical products used in infusion therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 15,000 full-time employees. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
Follow-Up Questions
What is ICU Medical Inc (ICUI)'s P/E Ratio?
The P/E ratio of ICU Medical Inc is N/A
Who is the CEO of ICU Medical Inc?
Mr. Vivek Jain is the Chairman of the Board of ICU Medical Inc, joining the firm since 2014.
What is the price performance of ICUI stock?
The current price of ICUI is 133.03, it has increased 0% in the last trading day.
What are the primary business themes or industries for ICU Medical Inc?
ICU Medical Inc belongs to Health Care industry and the sector is Health Care
What is ICU Medical Inc market cap?
ICU Medical Inc's current market cap is $3.2
Is ICU Medical Inc a buy, sell, or hold?
According to wall street analysts, 7 analysts have made analyst ratings for ICU Medical Inc, including 4 strong buy, 6 buy, 2 hold, 0 sell, and 4 strong sell
